Met Life Investment Management, LLC Guardant Health, Inc. Transaction History
Met Life Investment Management, LLC
- $18.1 Billion
- Q1 2025
A detailed history of Met Life Investment Management, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 70,173 shares of GH stock, worth $2.68 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
70,173
Previous 72,149
2.74%
Holding current value
$2.68 Million
Previous $2.2 Million
35.62%
% of portfolio
0.02%
Previous 0.01%
Shares
48 transactions
Others Institutions Holding GH
# of Institutions
393Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$461 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$429 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$208 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$197 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$193 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.9B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...